White Papers

White Paper Download

The Key to Optimizing Clinical Trials

As budgets and resources tighten, biopharmaceutical firms and CROs are under pressure to conduct cost-effective, risk-based monitoring of clinical trials. But for many, progress in this area has been slow. But why? And what's helping or hindering the adoption process? In August 2013, Applied Clinical Trials and SAS decided to find out. Working with Strategic Research to conduct in-depth telephone interviews with biopharmaceutical companies and contract research organizations, we gathered insights from directors and senior executives in clinical data management, biostatistics and clinical trial operations. This paper summarizes our findings, including barriers to implementing risk-based monitoring, suggestions for moving forward, and what the ideal system would look like.

Have a SAS profile? Log in to pre-fill the form.

*  First Name
*  Last Name
*  E-mail Address
* Organization/Company
* Industry
* Job Title
*  Country
(Required for Canada and U.S.)
* Business Phone
Yes, I would like to opt-in to receive occasional emails from SAS and its affiliates
about SAS events, free white papers, special offers on training and publications, etc.
All personal information will be handled in accordance with the SAS Privacy Statement.

( * indicates required field )